1. Home
  2. SGRP vs LSTA Comparison

SGRP vs LSTA Comparison

Compare SGRP & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGRP
  • LSTA
  • Stock Information
  • Founded
  • SGRP 1967
  • LSTA 1980
  • Country
  • SGRP United States
  • LSTA United States
  • Employees
  • SGRP N/A
  • LSTA N/A
  • Industry
  • SGRP Business Services
  • LSTA Misc Health and Biotechnology Services
  • Sector
  • SGRP Consumer Discretionary
  • LSTA Health Care
  • Exchange
  • SGRP Nasdaq
  • LSTA Nasdaq
  • Market Cap
  • SGRP 24.5M
  • LSTA 20.9M
  • IPO Year
  • SGRP 1996
  • LSTA N/A
  • Fundamental
  • Price
  • SGRP $0.99
  • LSTA $2.87
  • Analyst Decision
  • SGRP
  • LSTA Strong Buy
  • Analyst Count
  • SGRP 0
  • LSTA 1
  • Target Price
  • SGRP N/A
  • LSTA $15.00
  • AVG Volume (30 Days)
  • SGRP 40.8K
  • LSTA 15.2K
  • Earning Date
  • SGRP 08-13-2025
  • LSTA 08-11-2025
  • Dividend Yield
  • SGRP N/A
  • LSTA N/A
  • EPS Growth
  • SGRP N/A
  • LSTA N/A
  • EPS
  • SGRP N/A
  • LSTA N/A
  • Revenue
  • SGRP $196,814,000.00
  • LSTA $1,000,000.00
  • Revenue This Year
  • SGRP N/A
  • LSTA N/A
  • Revenue Next Year
  • SGRP N/A
  • LSTA N/A
  • P/E Ratio
  • SGRP N/A
  • LSTA N/A
  • Revenue Growth
  • SGRP N/A
  • LSTA N/A
  • 52 Week Low
  • SGRP $0.95
  • LSTA $1.87
  • 52 Week High
  • SGRP $2.48
  • LSTA $4.20
  • Technical
  • Relative Strength Index (RSI)
  • SGRP 40.61
  • LSTA 62.47
  • Support Level
  • SGRP $0.95
  • LSTA $2.36
  • Resistance Level
  • SGRP $1.08
  • LSTA $3.07
  • Average True Range (ATR)
  • SGRP 0.04
  • LSTA 0.21
  • MACD
  • SGRP -0.01
  • LSTA 0.04
  • Stochastic Oscillator
  • SGRP 37.23
  • LSTA 76.26

About SGRP SPAR Group Inc.

SPAR Group Inc is a merchandising and brand marketing services company, providing a broad range of sales-enhancing services to retailers across classes of trade and consumer goods manufacturers and distributors. It also provides a range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from the Americas.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: